June 11, 2007 NASD OTC-BB: MRDAF

Belgium Medical Signs Contract for Exclusive Distribution of the LAPEX 2000 LipoLaser for the South Eastern United States

Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that its North American distributor, Belgium Medical Inc. ("MMI") has signed an exclusive contract with Lifeline Medical Technology, LLC ("LifeLine")for the marketing and sales of Meridian's LAPEX 2000 LipoLaser.

The contract outlines that LifeLine will be granted an exclusive license to market the LAPEX 2000 LipoLaser in the states of Florida and Georgia. Their exclusive distributorship for the LAPEX 2000 LipoLaser is based on a minimum order volume equal to sales of approximately US $2.3 million for the initial 12-month period of the agreement.

"With an experienced management team, and an aggressive marketing plan we are very excited about launching this product to medical facilities and wellness spas," says Chris Male, president of LifeLine.

More About: LAPEX 2000 LipoLaser

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

More About: LifeLine Medical Technology, LLC

LifeLine Medical Technology is an affiliate of the PMG Group of Companies that began in 1997 to own and operate renal care centers in the southeastern US. Recently, they have evolved to include health and wellness products in its service line. LifeLine Medical Technology, LLC may be reached at [email protected].

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca